No Data
No Data
No Data
No Data
No Data
Express News | Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas With Met Fusion Gene
ReutersApr 25 08:30 ET
Express News | Apollomics Inc Files For Mixed Shelf Of Up To $200M
Moomoo 24/7Apr 1 16:34 ET
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. The market value of their outstanding shares is at $7.4 million. Galecto (NASDAQ:GLTO) shares in
BenzingaApr 1 16:31 ET
Apollomics Price Target Cut to $6.50/Share From $11.00 by EF Hutton
Apollomics Price Target Cut to $6.50/Share From $11.00 by EF Hutton
Dow JonesApr 1 08:48 ET
Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)
TipRanksApr 1 06:30 ET
Apollomics Is Maintained at Buy by HC Wainwright & Co.
Apollomics Is Maintained at Buy by HC Wainwright & Co.
Dow JonesApr 1 06:28 ET
pwh11kmo27 : hi bro.. any opinions with this dip?
No Data
No Data